Form D · Biotechnology

PROLOR Biotech, Inc.

Nes Ziona, L3 · CIK 0001268659

Offering snapshot reported Mar 25, 2010 · SEC filing

Reported sold
$24.4M
Offering amount: $24.4M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 17, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 25, 2010Initial$24,399,991No comparison18SEC filing
Aug 6, 2009Initial$2,000,000No comparison4SEC filing
May 24, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$216K (estimated)
Finders' fees
$0
Form D file number
021-66328

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Jeffries & Company2347
Dominick & Dominick7344

Source: Form D, filed Mar 25, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fuad Fares Director, Executive
Eyal Fima Executive
Phillip Frost Director
Marian Gorecki Director
Abraham Havron Director, Executive
Jane H. Hsiao Director
Shai Novik Director, Executive
Steven D. Rubin Director
Steve Schaeffer Executive
Adam Stern Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3 Sapir Street Weizmann Science Park
Nes Ziona, L3, 74140